Head-to-head · WeighScore
Livea vs Sunlight.com
The verdict
Sunlight.com takes it — 85.4/100 to 69.7/100.
Sunlight.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the cheapest published rates in the ranking — semaglutide $88/mo, tirzepatide $157/mo, flat and stated never to rise — from a LegitScript-certified telehealth with two named, NPI-verified physicians.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Livea | Sunlight.com |
|---|---|---|
| WeighScore | 69.7/100 | 85.4/100 |
| Grade | C | B |
| Scorecard rank | #132 | #7 |
| Semaglutide | $99/mo (plus a separate fee, compounded) | $88/mo |
| Tirzepatide | $199/mo (compounded) | $157/mo |
| Coverage | 4 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #132 · C
Strengths
- LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
- Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
- Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
- 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
- Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible
Where it loses points
- Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
- Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
- Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
- Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
- Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets
Graded #7 · B
Strengths
- Cheapest published semaglutide in this ranking ($88/mo) with competitively priced tirzepatide ($157/mo), both flat and stated to never increase — not quiz-gated, the FAQ states the exact figures
- LegitScript-certified with two named physicians and public NPI numbers (Lion MD network), rather than an anonymous "licensed clinicians" claim
- No membership fee, cancel anytime, free shipping in 1-2 days, a fresh 4-week supply every month
- All 50 states served, plus a separate live NAD+ program on the same domain
Where it loses points
- Injection only — the hero banner's "Injections and oral options available" line does not match the live site: no oral GLP-1 product page exists and sunlight.com/oral-semaglutide/ 404s
- The $157 tirzepatide figure sits inside a collapsed FAQ accordion rather than the hero, so it takes one extra click to find even though it is genuinely on the page
- Sermorelin is marketed as "launching soon" and is not yet live — do not expect it today
- No published lab or monitoring cadence, and the compounding pharmacy partner is referenced only generically, not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.